ANIK FY 2012 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$204M

FY 2012 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$71M+10.2% YoY

Gross Profit

$42M59.4% margin

Operating Income

$20M27.6% margin

Net Income

$12M16.5% margin

EPS (Diluted)

$0.82

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$142M

Total Liabilities

$33M

Stockholders' Equity

$109M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71M	$65M	+10.2%
Gross Profit	$42M	$38M	+11.5%
Operating Income	$20M	$14M	+41.2%
Net Income	$12M	$8M	+38.9%